Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/25 16:15 | 11/2/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | 2 | M.d | 8 | 1.72 | 0 | 5 | 7 | 77 | D | ||||||||||||||
11/4/25 16:15 | 11/3/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | 2 | S.d | -8 | 1.72 | 0 | -5 | 77 | D | |||||||||||||||
11/4/25 16:15 | 11/2/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Scimeca Dario | NC | O | GC,Secre | 2 | M.d | 4 | 1.73 | 0 | 3 | 10 | 28 | D | ||||||||||||||
11/4/25 16:15 | 11/3/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Scimeca Dario | NC | O | GC,Secre | 2 | S.d | -4 | 1.73 | 0 | -3 | 28 | D | |||||||||||||||
11/4/25 16:15 | 11/2/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | 2 | M.d | 22 | 1.72 | 0 | 13 | 13 | 116 | D | ||||||||||||||
11/4/25 16:15 | 11/3/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | 2 | S.d | -22 | 1.72 | 0 | -13 | 116 | D | |||||||||||||||
9/30/25 07:00 | 9/26/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Frankel Stanley | NC | D | 1 | P | 13 | 4.97 | 0 | 3 | 19 | 17 | D | |||||||||||||||
9/24/25 07:00 | 9/22/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Brown Melinda | NC | D | 1 | P | 7 | 4.89 | 0 | 1 | 7 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |